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Abstract 
Bifidobacterium is a genus of anaerobic bacteria that are commonly found to inhabit the 
gastrointestinal tract of many members of the animal kingdom. These microorganisms are 
adapted to obtain their carbon from the breakdown of complex carbohydrates. Marmosets, a 
mammal whose gut microbiome is inhabited by high levels of Bifidobacteria, consume gum 
Arabic as a major part of their diet. The purpose of this experiment is to determine whether 
Bifidobacterium strains isolated from the guts of marmosets are able to degrade and ferment this 
complex carbohydrate or one of its main constituents, arabinose. This was accomplished by 
inoculating isolates of Bifidobacterium species into tubes containing basal MRS medium 
supplemented with gum Arabic or arabinose and monitoring pH (color change) over time. Each 
of the 12 marmoset-derived isolates were tested in liquid media containing either 5% arabinose, 
3% gum Arabic, or 1% gum Arabic. A positive phenotype indicating fermentation of the 
substrate was visualized by a shift in the media’s color from purple to yellow. The fermentative 
capabilities of the marmoset strains were then compared to 13 other Bifidobacterium strains that 
were isolated from other mammals such as rats, pigs, and humans. Two strains from each group 
expressed a negative phenotype for arabinose, while all other strains were positive. In the 
marmoset group, 6 of the strains expressed positive phenotypes for the 1% gum and 8 were 
positive for the 3% concentration. The group of strains from non-marmoset origins sported 5 
positive phenotypes for the 1% concentration of gum Arabic, while 6 strains tested positive for 
the 3% concentration. 
 Keywords: microbiology, gut microbiota, Bifidobacteria, fermentation, marmoset, 
arabinose, gum Arabic, diet 
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Introduction 
 Bacterial species composition of the gut microbiome is individualized, but a 
relatively small set of about 20 species are typically found in most humans.  These include 
species of Bacteriodes, Prevotella, Ruminococcus, Coprococcus, Blautia, Eubacterium, 
Roseburia, and Bifidobacterium (Qin et al., 2010).  These species dominate the colonic 
microbiome and play important roles in directing the flow of carbon from degradation of 
complex fibers and other food components to different short chain fatty acids in the colon. 
Bifidobacterium is a genus of Gram-positive bacteria that frequently reside within the digestive 
tracts of insects and mammals (Milani et al., 2015). Species that commonly inhabit the 
gastrointestinal tracts of humans and other mammals include B. longum, B. bifidum, B. animalis, 
B. breve, B. adolescentis, and B. catenulatum (Grönlund et al., 2007). As infants, 
Bifidobacterium species make up between 60% and 70% of the human gut microbiome. This 
number slowly declines until the individual reaches adulthood and the relative abundance 
remains steady at 2-14% (Arboleya, Watkins, Stanton, & Ross, 2016). While there is very little 
data available that quantifies their prominence within the microbiota of non-human mammals, it 
is known that humans, primates, and domesticated mammals exhibit a remarkably high 
abundance of Bifidobacteria in comparison to other species (Milani et al., 2017). Species within 
the genus can be quite variable between the different hosts that they inhabit. Unlike humans, the 
primary Bifidobacterium species commonly found within the gut microbiome of the common 
marmoset (Callithrix jaccus) include B. reuteri, B. callitrichos, B. saguini, B. stellenboschense, 
B. biavatti, B.aesculapii, B. myosotis, B. tissieri, and B. hapali (Endo et al., 2012; Modesto et al., 
2014; Michelini et al., 2016). 
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In humans, Bifidobacterium populations within the gut microbiota have been shown to 
play a central role in disease prevention and gut homeostasis. The latter has historically been 
attributed to competitive exclusion of enteric and other pathogenic organisms, but recent studies 
have revealed far more intricate interactions between host and microbiota influence a wide range 
of metabolic and inflammatory diseases (Tojo et al., 2014). In humans, Bifidobacterium species 
play important roles early in life and the early colonizing species can selectively ferment unique 
human milk oligosaccharides (HMOs) found in breastmilk. These non-digestible sugars act as 
pre-biotics for the Bifidobacteria, which then provide significant health benefits to their hosts 
(Lewis et al., 2015). Bifidobacteria are known to ferment carbohydrates, both simple and 
complex, as their primary source of carbon. Their ability to break down complex polysaccharides 
that the host organism is unable to digest by itself is another important characteristic of host-
Bifidobacteria mutualism (Flint, Scott, Duncan, Louis, & Forano, 2012). 
Marmosets are small omnivorous monkeys native to Brazil. Their diet primarily consists 
of fruits, flowering plants, insects, lizards, and invertebrates, but they also supplement their diets 
with tree gums from various indigenous tree species (Passamani & Rylands, 2000; Caton, Hill, 
Hume, & Crook, 1996).  When preferred foods (e.g. fruits and flowering plants) become scarce, 
marmosets will spend a large proportion of their time (up to 70%) obtaining gums and exudates 
from trees in their local environment (Power, 1996; Ferrari & Ferrari, 1989). These gums 
comprise large polysaccharide chains, often with ornate branching patterns that are generally 
believed to be degraded in the colon by members of the colonic microbiota.  Recent work on the 
gut microbiota of captive populations of the common marmoset have found significant levels of 
Bifidobacterium species in adult animals (Albert, Rani, & Sela, 2018).  Gum Arabic is a 
naturally-occurring non-starch complex carbohydrate that is made up of the hardened sap of 
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acacia trees. Its makeup consists of rhamnose, galactose, glucuronic acid, and arabinose (Butler 
& Cretcher, 1929; Osman, Williams, Menzies, & Phillips, 1993). The purpose of this experiment 
is to determine whether Bifidobacterium strains isolated from the fecal samples of marmosets are 
able to ferment gum Arabic or its main component, arabinose. Non-marmoset strains will also be 
measured for their ability to ferment gum Arabic and arabinose.  
 
Methods 
The marmosets used in this experiment were fed ZuPreem® Marmoset Diet, along with 
fruit like bananas, apples, apple sauce, melons, and oranges. Additionally, they were fed meal 
worms and scrambled eggs several times per week as a source of supplemental animal protein. 
Each marmoset received Mazuri® Enrichment Gum Arabic on a daily basis. Each cage had 2 mL 
of a 0.5 g/mL solution mixed in with their food, for a total of 1 g of the gum per day per cage. 
Isolates of Bifidobacterium species were obtained from the fecal samples of seven adult 
marmosets and diluted 1:10 with PBS buffer and homogenized. Homogenized fecal samples 
were serial diluted and plated on MRS and BSIM, or Bifidobacterium Selective Iodoacetate 
Mupirocin (Lewis et al., 2015). The animal designation and isolation medium are indicated in 
the character string of each strain ID such that each isolate has a unique ID. For example, 
Bifidobacterium MM5-B-2 was isolated from marmoset no. 5, plated on Bifidobacterium 
selective agar, and sampled from colony no. 2. Alternately, strain MM4-M-3 was retrieved from 
marmoset no. 4, plated on solid MRS, and sampled from colony no. 3 on the plate. 
The non-marmoset Bifidobacterium strains were obtained from The Agricultural 
Research Service Culture Collection (NRRL) Online Catalog, each arriving in a dormant state 
inside sealed glass tubes. The cells were reactivated by first scratching the center of the tube with 
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a file, then wiping it down with 70% alcohol. After the tube was opened and the end flamed, the 
contained cell pellet was transferred to 2 mL of Difco™ Lactobacilli MRS Broth. The solution 
was then vortexed by hand, and 500 µL of the suspension was added to a 1.5 mL tube containing 
500 µL of glycerol. This formed the stock solution for each inoculum, which were stored at -
80°C. The marmoset inoculum solutions consisted of similar 1.5 mL tubes of glycerol/MRS 
solution. 
Colonies were inoculated into MRS broth and enriched anaerobically at 37ºC for 24 
hours. DNA was extracted from all 25 isolates using the method from Martínez, Kim, Duffy, 
Schlegel, & Walter (2010). Extractions were performed by first warming 10% SDS and 
precooling the centrifuge to 4°C. Next, the isolates were centrifuged to collect 1 mL of cells at 
8,000 x g for 5 minutes. The samples were washed once with cold PBS buffer (pH = 7) then 
vortexed and centrifuged again at 8,000 x g for 5 minutes. The 1 mL was discarded after 
spinning, leaving the pellet undisturbed. Next, the pellet was resuspended with 750 µL lysis 
buffer. For this step, 20 mg of lysozyme was added per 1 mL of buffer, then filter sterilized. The 
lysis buffer with the resuspended pellet was then transferred to a bead beating tube containing 
300 mg of zirconium beads (0.1 mm, BioSpec products) and incubated at 37°C for 30 minutes. 
After incubating, 85 µL of 10% SDS solution and 40 µL of proteinase K (15 mg/mL) were 
added. The solution was then vortexed and incubated for 15 minutes at 60°C, and 500 µL of 
phenol:chloroform:isoamyl alcohol (25:24:1) was added. Cells that did not lyse with enzymatic 
lysis were then disrupted using a bead beater (BioSpec products) set on high (homogenize) for 2 
minutes. The samples were removed from the bead beater, placed on ice, and transferred to the 
centrifuge to be spun at 10,000 x g for 5 minutes. The top layer was then moved into a 1.5 mL 
Eppendorf tube. 500 µL of phenol:chloroform:isoamyl alcohol was added to the new tube, which 
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was then vortexed, spun at 10,000 x g for 5 minutes, and had top layer carefully removed into a 
new 1.5 mL Eppendorf tube. This process was repeated once more with 
phenol:chloroform:isoamyl alcohol, then twice more with chloroform:ioamyl alcohol. Next, 2 
volumes of EtOH (96-100%) were added to the samples and left overnight at –20°C. The 
samples were then centrifuged at full speed for 20 minutes, and the ethanol was discarded 
without disturbing the DNA pellet inside. The pellet was washed by adding 500 µL of 70% 
EtOH and spinning at full speed for 20 minutes. The liquid was carefully discarded, and the 
DNA pellet was left to dry for 30 minutes or until dry at room temperature. Finally, the DNA 
was resuspended in DNA in 100 µL of H2O and left at 4°C overnight. 
After DNA extraction, the quality and concentration of DNA was checked using the 
NanoDrop (Table 3). The PCR protocol recipe and conditions can be found below in Tables 1 
and 2. The primers 8F (5'-AGAGTTTGATCCTGGCTCAG-3') (Turner, Pryer, Miao, & Palmer, 
1999) and 16SU2 (5'-ATCGGYTACCTTGTTACGACTT-3') (Benson et al., 2014) were used to 
amplify the bacterial 16S rRNA gene. After amplifying the 16S rRNA gene through PCR, the 
PCR products underwent 1% agarose gel electrophoresis to confirm PCR success. Results from 
the gel indicate that the amplified section DNA from each strain was around 1,500 bp in length. 
A picture of the gel under UV light is provided in Figure 4.  PCR products were then purified 
using QIAGEN QIAquick® PCR Purification Kit. Purified PCR products were Sanger sequenced 
in both directions with the 8F and 16SU2 primers at Michigan State University RTSF Genomics 
Core. Version 7.0 of MEGA (2016) was used to assemble a consensus sequence from each 
isolate. Consensus sequences were BLASTed against the NCBI database and the top three 
identities for each isolate were recorded (Table 3).  
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For PCR amplification, a 1.5 mL tube was used for the PCR mix, into which all 
ingredients listed in Table 1 (except for the DNA) were added. The Ex Taq was thawed in the 
fridge, while all other ingredients were left to thaw at room temperature. Into microcentrifuge 
tubes, 49 µL of the PCR mix was added, as well as 1 µL of the DNA sample being amplified. 
These tubes were then placed in a thermocycler to undergo PCR amplification. The ingredients 
of the PCR mix were as follows: 5 µL of 10X buffer, 4 µL of dNTP mix, 1 µL each for the 8F 
forward and 16SU2 reverse primers, 0.25 µL of Ex Taq polymerase, 37.75 µL of H2O, and 1 µL 
of DNA. All ingredients were scaled up as needed for the amount of DNA used. The 
thermocycler was programmed to run the pre-denaturation step at 95°C for 2 minutes, the 
denaturation step at 95°C for 30 seconds, the annealing phase at 55°C for 45 seconds, and the 
extension step at 72°C for 45 seconds. The denaturation, annealing, and extension steps went 
through a total of 29 cycles before moving on to the final extension step, which was run at 72°C 
for 5 minutes. 
For the fermentations, tubes containing 5 mL of MRS broth were left in an anaerobic 
chamber overnight to ensure the removal of any oxygen inside. The following day, the pure 
frozen stock cultures were introduced into the anaerobic chamber. These were inoculated into 
each tube and incubated at 37ºC for 72 hours. Next, three sets of tubes containing bMRS and 
either 1% gum Arabic, 3% gum Arabic, or 5% arabinose were placed in the anaerobic chamber 
overnight.  The formula for 500 mL of bMRS is as follows: 5 g protease peptone no. 3, 5 g beef 
extract, 2.5 g yeast extract, 0.93 g Tween 80, 1 g ammonium citrate dibasic, 2.5 g sodium acetate 
trihydrate, 0.05 g magnesium sulfate heptahydrate, 1 g dipotassium phosphate, 0.025 g 
manganese sulfate, and 30 mg bromocresol purple. These ingredients were then added to 450 mL 
of boiling water, then stirred until dissolved, and autoclaved. Next, a 50 mL of a filter-sterilized 
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stock solution of the desired carbohydrate was added. To ultimately obtain media containing 5% 
arabinose by mass, the stock solution of 25% was made by dissolving 12.5 g of the carbohydrate 
in 50 mL of distilled water. Stock solutions of gum Arabic for the 3% and 1% media were made 
by dissolving 7.5 g and 2.5 into 50 mL of distilled water, respectively. Next in the fermentation 
process, 40 µL of the 72-hour culture tubes was used to inoculate each of the fermentation tubes. 
These new tubes were then placed in the incubator for  72 hours, then removed and analyzed for 
a color change. Successful fermentation of the carbohydrate within was indicated by shift in the 
media from purple color to a yellowish hue.  
 
Results 
Data on PCR product quality is found in Table 3, which lists DNA concentration of the 
product and indicates whether phenol contamination was detected in the samples. This 
information was gathered using a NanoDrop spectrophotometer. Contamination and low DNA 
concentration are both factors that can negatively impact the accuracy of sequencing results. 
Three samples were found to be contaminated with phenol, but no samples had problematically 
low concentrations of DNA. In addition to NanoDrop analysis, the PCR products underwent 
agarose gel electrophoresis to confirm successful amplification of an expected size product. 
Results from the gel electrophoresis indicate that the amplified section of DNA from each strain 
was around 1,500 bp in length, which is the appropriate size for the 16S rRNA gene. An image 
of the gel stained with ethidium bromide under UV light is provided in Figure 1. 
The data in Table 2 contains information about the possible identities of all 25 
Bifidobacterium strains. This information was obtained by Sanger sequencing of the samples and 
BLASTing their consensus sequences against the NCBI database. The identities of most non-
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marmoset strains were confirmed to be of the correct species, if not the correct strain or 
subspecies. The exceptions to this are B. bifidum ATCC 11617, B. suis ATCC 27533, 
Bifidobacterium sp. 12_1_47BFAA, and Bifidobacterium sp. 113. Bifidobacterium sp. 113 came 
back as 100% query cover and 100% identity, despite the mistaken identity. Meanwhile, 
Bifidobacterium sp. 12_1_47BFAA came back with some of the lowest scores of all the strains 
in both categories.  Possible explanations for any discrepancies in identity are provided in the 
Discussion section of this paper. 
 Of the marmoset strains, MM5-B-8 had the lowest scores in both identity and query 
cover, and it should be noted that it was one of just three PCR samples that were contaminated 
with phenol. B. reuteri and Bifidobacterium sp. strain LMG 30940 each had 3 hits, making them 
the most frequently observed alignments. B. myostosis, B. saeculare, B. callitrichidarum, B. 
areophilum, B. aesculapii, B. scardovii, B. thermophilum, Bifidobacterium sp. strain TRE_F, 
Bifidobacterium sp. strain TRE_2, and Bifidobacterium sp. strain TRE_H all had two hits each. 
Many of the marmoset strains shared two or three of their top hits. In total, 21 unique strains 
were listed as possible identities for the marmoset isolates, and 6 of these strains were not from a 
specific species. MM4-B-6 and MM5-B-8 were the only two isolates with <90% identity scores, 
while all other marmoset isolates scored above 95% identity. Ten of the marmoset strains had at 
least one hit with an identity score of over 97%. 
For the fermentation tests, a positive phenotype is expressed as a yellow color change in 
the medium. This is indicative of acidification (pH < 6) resulting from the fermentation process. 
An intermediate phenotype is brought about by mild acidification, and results in a greenish-
purple color change. The pH of the medium in these conditions is about 6.5. No color change 
indicates a negative phenotype and a lack of fermentation. Examples of images from positive, 
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intermediate, and negative phenotypes for each substrate can be seen in Figures 2, 3, and 4. All 
strains cultured in arabinose expressed either a positive or negative phenotype, while 
intermediate phenotypes were common for both concentrations of gum Arabic. Color changes 
indicating a positive or intermediate phenotype were considerably starker in the fermentation 
tubes containing 5% arabinose than they were for either concentration of gum Arabic. 
Intermediate phenotypes appeared more frequently in the non-marmoset strains. Nearly all 
Bifidobacterium strains, marmoset or non-marmoset, indicated some ability to ferment the 5% 
arabinose, as well as the gum Arabic at both 1% and 3% concentrations. With the exception of 
MM5-B-9, any strain expressing a negative phenotype for one substrate expressed the same for 
the others. The results of the fermentation tests are shown in Table 2. 
 
Tables and Figures 
Table 1 
Ability of Various Bifidobacterium Strains to Ferment Arabinose and Gum Arabic 
Strain Arabinose 1% Gum Arabic 3% Gum Arabic 
B. longum ssp. longum (ATCC® 
15707™) 
+ + + 
B. longum longum JDM301 + + + 
B. longum DJO10A - - - 
Bifidobacterium sp. 12_1_47BFAA + + + 
Bifidobacterium sp. 113 + i i 
B. adolescentis ATCC 15703 + i i 
B. adolescentis L2-32 + + + 
B. adolescentis IVS-1 + i i 
B. animalis ssp. animalis + i i 
B. bifidum ATCC 11617 + + + 
B. animalis ssp. lactis + i i 
B. suis ATCC 27533 - - - 
B. breve + i + 
MM5-B-8 + i + 
MM5-B-9 + - - 
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MM3-M-6 + i + 
MM4-B-6 - - - 
MM4-M-3 + + + 
MM5-B-2 - - - 
MM9-B-2 + + + 
MM8-B-4 + i i 
MM8-B-9 + + + 
MM8-M-5 + + + 
MM10-M-9 + + + 
MM9-B-6 + + + 
Note. A (+) signifies a positive phenotype and indicates a strong ability to metabolize the 
substrate as an energy source. Cells marked with a (-) indicate a negative phenotype and an 
inability to ferment the substrate, while an (i) indicates an intermediate phenotype and a low 
level of metabolic activity. 
 
Table 2 
Bifidobacterium Strain Identification Using BLAST® 
Strain Name Possible Strain Identity 
Query 
Cover 
Identity 
MM5-B-2 
Bifidobacterium reuteri strain AFB22-1 16S ribosomal RNA gene, 
partial sequence 
100% 98.41% 
 
Bifidobacterium boum strain LET414 16S ribosomal RNA gene, 
partial sequence 
99% 97.44% 
 
Bifidobacterium thermophilum strain NB-168 16S ribosomal RNA 
gene, partial sequence 
100% 97.03% 
    
MM4-M-3 
Bifidobacterium sp. strain LMG 30940 16S ribosomal RNA gene, 
partial sequence 
100% 97.83% 
 
Bifidobacterium pseudocatenulatum strain CCFM8408 16S 
ribosomal RNA gene, partial sequence 
100% 97.67% 
 
Bifidobacterium angulatum gene for 16S ribosomal RNA, partial 
sequence, strain: JCM 7096 
100% 97.67% 
    
B. breve 
Bifidobacterium breve strain NCTC11815 genome assembly, 
chromosome: 1 
100% 99.85% 
 
Bifidobacterium breve strain FDAARGOS_561 chromosome, 
complete genome 
100% 99.85% 
 
Bifidobacterium breve strain DRBB30 chromosome, complete 
genome 
100% 99.85% 
    
MM9-B-6 
Bifidobacterium sp. MRM 9.26 16S ribosomal RNA gene, partial 
sequence 
100% 99.21% 
 
Bifidobacterium myosotis strain MRM_5.10 16S ribosomal RNA 
gene, partial sequence 
100% 97.64% 
 
Bifidobacterium sp. strain TRE_F 16S ribosomal RNA gene, partial 
sequence 
96% 98.98% 
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B. longum ssp. 
longum (ATCC® 
15707™) 
Bifidobacterium longum strain HBUAS54272 16S ribosomal RNA 
gene, partial sequence 
100% 99.66% 
 
Bifidobacterium longum ssp. suillum strain S3 16S ribosomal RNA 
gene, partial sequence 
100% 99.66% 
 
Bifidobacterium longum strain NCTC11818 genome assembly, 
chromosome: 1 
100% 99.66% 
    
MM8-B-4 
Bifidobacterium hapali strain MRM_8.14 16S ribosomal RNA, 
partial sequence 
100% 99.49% 
 
Bifidobacterium sp. MRM 9.16 16S ribosomal RNA gene, partial 
sequence 
100% 99.49% 
 
Bifidobacterium myosotis strain MRM_5.9 16S ribosomal RNA, 
partial sequence 
100% 96.71% 
    
MM9-B-2 
Bifidobacterium myosotis strain MRM_5.9 16S ribosomal RNA, 
partial sequence 
100% 99.36% 
 
Bifidobacterium sp. strain TRE_F 16S ribosomal RNA gene, partial 
sequence 
100% 98.88% 
 
Bifidobacterium saeculare strain LET 415 16S ribosomal RNA 
gene, partial sequence 
100% 97.92% 
    
B. suis ATCC 
27533 
Bifidobacterium longum ssp. suis strain VB-5/9 16S ribosomal RNA 
gene, partial sequence 
100% 99.71% 
 
Bifidobacterium longum strain Su859 genome assembly, 
chromosome: I 
100% 99.71% 
 
Bifidobacterium longum strain TPY3-2 16S ribosomal RNA gene, 
partial sequence 
100% 99.71% 
    
B. bifidum ATCC 
11617 
Bifidobacterium gallinarum strain CACC 514 chromosome 
CACC514, complete sequence 
100% 99.71% 
 
Bifidobacterium pullorum gene for 16S ribosomal RNA, partial 
sequence, strain: JCM 1214 
100% 99.42% 
 
Bifidobacterium saeculare strain LET 415 16S ribosomal RNA 
gene, partial sequence 
100% 99.13% 
    
MM3-M-6 
Bifidobacterium reuteri strain AFB22-1 16S ribosomal RNA gene, 
partial sequence 
100% 98.08% 
 
Bifidobacterium longum ssp. infantis strain NCTC11817 genome 
assembly, chromosome: 1 
100% 96.63% 
 
Bifidobacterium sp. strain TRE_H 16S ribosomal RNA gene, partial 
sequence 
98% 97.56% 
    
B. longum DJO10A Bifidobacterium longum DJO10A, complete genome 100% 99.70% 
 
Bifidobacterium longum strain NWAFU0001 16S ribosomal RNA 
gene, partial sequence 
100% 99.70% 
 
Bifidobacterium longum strain HBUAS55017 16S ribosomal RNA 
gene, partial sequence 
100% 99.70% 
    
MM5-B-8 
Bifidobacterium reuteri strain AFB22-1 16S ribosomal RNA gene, 
partial sequence 
92% 87.46% 
 
Bifidobacterium boum strain LET414 16S ribosomal RNA gene, 
partial sequence 
90% 84.29% 
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Bifidobacterium thermophilum strain NB-168 16S ribosomal RNA 
gene, partial sequence 
90% 84.29% 
    
B. adolescentis 
ATCC 15703 
Bifidobacterium adolescentis strain ATCC 15703 16S ribosomal 
RNA, complete sequence 
100% 99.82% 
 
Bifidobacterium faecale strain CICC6176 16S ribosomal RNA gene, 
partial sequence 
100% 99.82% 
 
Bifidobacterium ruminantium gene for 16S ribosomal RNA, partial 
sequence, strain: JCM 8222 
100% 99.64% 
    
MM8-B-9 
Bifidobacterium sp. strain LMG 30940 16S ribosomal RNA gene, 
partial sequence 
100% 98.12% 
 
Bifidobacterium callitrichidarum strain TRI 5 16S ribosomal RNA, 
partial sequence 
100% 97.65% 
 
Bifidobacterium sp. strain TRE_2 16S ribosomal RNA gene, partial 
sequence 
100% 97.65% 
    
B. animalis ssp. 
lactis 
Bifidobacterium animalis ssp. lactis strain HN019 chromosome, 
complete genome 
100% 99.82% 
 
Bifidobacterium sp. strain BZ11 16S ribosomal RNA gene, partial 
sequence 
100% 99.82% 
 
Bifidobacterium sp. MC_3 partial 16S rRNA gene, strain DSM-
20219, isolate MC_3 
100% 99.82% 
    
MM4-B-6 
Bifidobacterium callitrichidarum strain TRI 5 16S ribosomal RNA, 
partial sequence 
99% 87.68% 
 
Bifidobacterium gallinarum strain CACC 514 chromosome 
CACC514, complete sequence 
97% 87.80% 
 
Bifidobacterium saeculare strain LET 415 16S ribosomal RNA 
gene, partial sequence 
97% 87.80% 
    
MM8-M-5 
Bifidobacterium aesculapii strain MRM 4/2 16S ribosomal RNA 
gene, partial sequence 
100% 97.68% 
 
Bifidobacterium scardovii JCM 12489 = DSM 13734 gene for 16S 
ribosomal RNA, partial sequence 
98% 95.77% 
 
Bifidobacterium aerophilum strain TRE 26 16S ribosomal RNA 
gene, partial sequence 
98% 95.48% 
    
B. animalis ssp. 
animalis 
Bifidobacterium animalis ssp. animalis strain CNCM I-4602 
chromosome, complete genome 
100% 100% 
 
Bifidobacterium animalis strain SJ19 16S ribosomal RNA gene, 
partial sequence 
100% 100% 
 Bifidobacterium sp. MC_8 partial 16S rRNA gene, isolate MC_8 100% 99.82% 
    
MM10-M-9 
Bifidobacterium aesculapii strain MRM 4/2 16S ribosomal RNA 
gene, partial sequence 
99% 97.88% 
 
Bifidobacterium scardovii JCM 12489 = DSM 13734 gene for 16S 
ribosomal RNA, partial sequence 
98% 95.93% 
 
Bifidobacterium aerophilum strain TRE 26 16S ribosomal RNA 
gene, partial sequence 
98% 95.33% 
    
MM5-B-9 
Bifidobacterium pseudocatenulatum strain CCFM8408 16S 
ribosomal RNA gene, partial sequence 
100% 98.51% 
 
Bifidobacterium sp. strain LMG 30940 16S ribosomal RNA gene, 
partial sequence 
100% 98.35% 
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Bifidobacterium sp. strain TRE_2 16S ribosomal RNA gene, partial 
sequence 
100% 98.35% 
    
B. 
adolescentis IVS-1 
Bifidobacterium adolescentis strain HBUAS55097 16S ribosomal 
RNA gene, partial sequence 
100% 99.26% 
 
Bifidobacterium faecale strain HBUAS55087 16S ribosomal RNA 
gene, partial sequence 
100% 99.26% 
 
Bifidobacterium sp. CCFM8400 16S ribosomal RNA gene, partial 
sequence 
100% 99.26% 
    
B. adolescentis L2-
32 
Bifidobacterium adolescentis strain HBUAS55097 16S ribosomal 
RNA gene, partial sequence 
100% 100% 
 
Bifidobacterium faecale strain HBUAS55087 16S ribosomal RNA 
gene, partial sequence 
100% 100% 
 
Bifidobacterium sp. CCFM8400 16S ribosomal RNA gene, partial 
sequence 
100% 100% 
    
Bifidobacterium 
sp. 12_1_47BFAA 
Bifidobacterium sp. PG13 16S ribosomal RNA gene, partial 
sequence 
99% 93.33% 
 
Bifidobacterium longum ssp. longum strain CCUG30698, complete 
genome 
93% 92.91% 
 
Bifidobacterium crudilactis strain C4/12B 16S ribosomal RNA gene, 
partial sequence 
85% 82.94% 
    
Bifidobacterium 
sp. 113 
Bifidobacterium adolescentis strain HBUAS55097 16S ribosomal 
RNA gene, partial sequence 
100% 100% 
 
Bifidobacterium faecale strain HBUAS55087 16S ribosomal RNA 
gene, partial sequence 
100% 100% 
 
Bifidobacterium sp. CCFM8400 16S ribosomal RNA gene, partial 
sequence 
100% 100% 
    
B. longum 
longum JDM301 
Bifidobacterium longum ssp. infantis strain NCTC11817 genome 
assembly, chromosome: 1 
100% 100% 
 
Bifidobacterium longum ssp. longum 16S ribosomal RNA gene, 
partial sequence 
100% 100% 
 Bifidobacterium longum strain BXY01, complete genome 100% 100% 
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Table 3 
PCR Product Spectrophotometer Results for Checking DNA Quality 
Strain ng/µL A260/A280 A260/A230 
B. longum ssp. longum (ATCC® 15707™) 115.0 1.82 1.24 
B. longum longum JDM301 131.4 1.77 1.34 
B. longum DJO10A 138.1 1.81 1.14 
Bifidobacterium sp. 12_1_47BFAA 134.7 2.07 2.13 
Bifidobacterium sp. 113 87.4 1.89 1.94 
B. adolescentis ATCC 15703 41.3 1.92 1.39 
B. adolescentis L2-32 233.3 1.80 1.63 
B. adolescentis IVS-1 117.6 1.91 1.63 
B. animalis ssp. animalis 85.3 1.86 1.73 
B. bifidum ATCC 11617 74.5 1.97 1.73 
B. animalis ssp. Lactis 63.9 1.72 0.90 
B. suis ATCC 27533 87.6 1.94 1.43 
B. breve 279.3 1.86 1.74 
MM5-B-8 500.6 2.01 1.61 
MM5-B-9 54.5* 1.54 0.97 
MM3-M-6 1492.2 2.03 1.68 
MM4-B-6 303.8 1.94 1.49 
MM4-M-3 40.4* 1.51 0.94 
MM5-B-2 2864.8 2.07 1.78 
MM9-B-2 270.1 1.85 1.29 
MM8-B-4 1289.6 2.03 2.11 
MM8-B-9 42.0 1.67 1.37 
MM8-M-5 56.3 1.91 1.29 
MM10-M-9 30.5 1.55 0.61 
MM9-B-6 249.8* 1.70 1.04 
Note. In the measurements marked with an (*) under the ng/µL column, the presence of phenol 
was detected in the sample. 
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Figure 1. PCR products of amplified 16S rRNA gene sequence of roughly 1,500 bp, viewed 
under UV light after undergoing agarose gel electrophoresis 
 
  
Figure 2. From left to right, one negative and three positive phenotypes for fermentation in 
media containing 5% arabinose. No intermediate phenotypes are depicted because no strains 
expressed an intermediate phenotype when incubated with this substrate. 
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Figure 3. From left to right, three negative phenotypes, one positive phenotype, and one 
intermediate phenotype for Bifidobacteria incubated in media containing 1% gum Arabic. 
 
 
Figure 4. From left to right, one negative phenotype, two intermediate phenotypes, and one 
positive phenotype for Bifidobacteria incubated in media containing 3% gum Arabic. 
 
Discussion 
The results of this experiment have shown that most of the Bifidobacterium strains were 
able to ferment arabinose, regardless of whether or not the strain originated from a marmoset. 
Only two strains in each group (marmoset vs. non-non-marmoset) tested negative, while all the 
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others had positive phenotypes. In the marmoset strains, there were more positive phenotypes 
detected than there were intermediate or negative phenotypes for the gum Arabic. This is true for 
either concentration; 6 out of 12 strains exhibited positive phenotypes for the 1% concentration, 
while 8 out of 12 did the same for the 3% concentration. Intermediate phenotypes were more 
common in the non-marmoset strains, accounting for 6 out of 13 strains for 1% concentration, 
and 5 out of 13 for the 3%. It is possible that this trend is a result of the marmoset strains being 
more well-adapted to utilizing gum Arabic as a carbon source.  
Some challenges arose during the fermentation testing that prevented obtaining more 
precise results. Initially, the experimental design called for the use of solid media. Each strain 
would first be grown in liquid MRS media, then plated on BSIM agar. A single colony would be 
picked from the plate and used to inoculate a new tube of liquid MRS. After incubation, a loop of 
inoculum would then be taken from this second tube and plated on solid basal MRS media 
containing bromocresol purple and the carbohydrate being tested for. Unfortunately, most of the 
Bifidobacteria would not grow after being plated on the solid media, and it became necessary to 
exclusively use liquid media for the fermentations. 
One of the weaknesses of the tube fermentation experiments is that the phenotype is 
indirect, observed by acidification of the medium.  It is presumed that the acid results from 
fermentation of the gum Arabic, however it is possible that impurities in the gum are being 
fermented.  Additional studies to detect breakdown of the gum itself during fermentation are 
needed to confirm actual degradation and fermentation of the gum.  Additionally, growth rates 
should be measured on the gum and other carbohydrate monomers like galactose and rhamnose, 
which are also constituents of the gum. It may be wise to explore how first treating the gum 
Arabic enzymatically or with acid hydrolysis that would be expected to occur in the stomach 
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would affect the ability of Bifidobacterium species to ferment the enzymatic or hydrolysis 
products. 
The results obtained from Sanger sequencing differed in precision between strains, as the 
size and accuracy of the sequences run through BLAST® were quite variable. Forward and 
reverse sequences for each strain were compared using MEGA7 software. For several strains, a 
large portion of the forward sequence would almost perfectly match a section the reverse 
compliment sequence. Only these closely matched consensus sequences were run through 
BLAST®, and the shorter queries that resulted from this may have not carried enough 
information to properly identify the sample when compared to genetically similar strains. For the 
samples that had significantly mismatched forward and reverse sequences, the entirety of both 
sequences were run through BLAST®. The top three hits from the sequence that came back with 
the best identity and query cover scores were recorded, and the information from the other 
sequence was disregarded. In theory, the compromised accuracy of the gene sequence is largely 
reconciled by using a much larger portion of the sequenced gene in the query. It should be noted 
that some of the Bifidobacteria that were isolated from the marmosets may be newly discovered 
strains, which further contributes to the uncertainty of their identities. Any discrepancies between 
the forward and reverse sequences may have occurred through contamination, poor DNA quality, 
or technical errors. 
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